References
- Nielsen AO, Pedersen L, Sode BF, Dahl M. β-Blocker therapy and risk of chronic obstructive pulmonary disease – a Danish nationwide study of 1.3 million individuals. EClinicalMedicine. 2019;7: 21–26.
- Corlățeanu A, Odajiu I, Botnaru V, Cemirtan S. From smoking to COPD – current approaches. Pneumologia. 2016;65(1): 20–23.
- Schnell K, Weiss CO, Lee T, Krishnan J, Leff B, Wolff JL, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: A cross-sectional study using data from NHANES 1999–2008. BMC Pulmonary Medicine. 2012;12: 26.
- Laforest L, Roche N, Devouassoux G, Belhassen M, Chouaid C, Ginoux M, et al. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study. Respiratory Medicine. 2016;117: 33–39.
- Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: What are the implications for clinical practice? Therapeutic Advances in Respiratory Disease. 2018; 12: 1–16.
- Rabe KF, Hurst JR, Suissa S. Cardiovascular disease and COPD: Dangerous liaisons? European Respiratory Revire. 2018;27: 180057.
- Krynytska I, Marushchak M, Zaets T, Savchenko I, Habor H. Investigation of bone mineralization in patients with coronary heart disease complicated by chronic heart failure, stage II-A. GMN. 2017;267: 43–48.
- Trinkmann F, Saur J, Borggrefe M, Akin I. Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)—current considerations for clinical practice. Journal of Clinical Medicine. 2019;8: 69.
- Marushchak M, Krynytska I, Mikolenko A, Andreychyn Y, Bodnar Y. Chronic heart failure causes osteopathy or is osteopathy a factor in development of chronic heart failure? AJPCR. 2018;11(1): 111–115.
- Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. European Heart Journal. 2005;26: 1887–1894.
- Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D. Unrecognised ventricular dysfunction in COPD. The European Respiratory Journal. 2012;39: 51–58.
- Wheaton AG, Ford ES, Cunningham TJ, Croft JB. Chronic obstructive pulmonary disease, hospital visits, and comorbidities: National Survey of Residential Care Facilities, 2010. Journal of Aging and Health. 2015;27: 480–499.
- Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478: 103–109.
- Ayada С, Toru Ü, Genç O. Evaluation of whether the ACE gene I/D polymorphism constitutes a risk factor for chronic obstructive pulmonary disease in the Turkish population. Genetics and Molecular Research. 2014;13(4): 10427–10433.
- Simsek S, Tekes S, Oral D. The insertion/deletion polymorphism in the ACE gene and chronic obstructive pulmonary disease. Genetics and Molecular Research. 2013;12(2): 1392–1398.
- Shanmuganathan R, Kumaresan R, Giri P. Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease. Journal of Postgraduate Medicine. 2015;61(4): 230–234.
- Yun CM, Sang XY. Role of proteinase-activated receptor-1 gene polymorphisms in susceptibility to chronic obstructive pulmonary disease. Genetics and Molecular Research. 2015;14(4): 13215–13220.
- Essa ES, Wahsh RA. Association between Plasminogen activator inhibitor-1-675 4G/5G insertion/deletion polymorphism and chronic obstructive pulmonary disease. COPD. 2016;13(6): 756–759.
- Wang W, Li P, Chen Y, Yang J. Association between β2-adrenergic receptor-16Arg/Gly gene polymorphism and chronic obstructive pulmonary disease risk: Systematic review and meta-analysis. Iran Journal of Public Health. 2014;43(7): 877–888.
- Kang SW, Kim SK, Chung JH, Jung HJ, Kim KI, Kim J, et al. Genetic polymorphism of angiotensin-converting enzyme and chronic obstructive pulmonary disease risk: An updated meta-analysis. BioMed Research International. 2016;2016: 7636123.
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. European Heart Journal. 2018;39(33): 3021–3104.
- Lechin M, Quiñones MA, Omran A, Hill R, Yu QT, Rakowski H, et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 1995;92: 1808–1812.
- Turner AJ, Hooper NM. The angiotensin converting enzyme gene family: Genomics and pharmacology. Trends in Pharmacological Science. 2002;23: 177–183.
- Pang S, Chubb AJ, Schwager SL, Ehlers MR, Sturrock ED, Hooper NM, et al. Roles of the juxtamembrane and extracellular domains of the angiotensin-converting enzyme in ectodomain shedding. The Biochemical Journal. 2001;358: 185–192.
- Parkin ET, Turner AJ, Hooper NM. Secretase-mediated cell surface shedding of the angiotensin converting enzyme. Protein & Peptide Letters. 2004;11: 423–432.
- Close P, Kehoe G, Miners S, Love S. Angiotensin in Alzheimer’s disease – friend or foe? Trends in Neuroscience. 2009;32: 619–628.
- Kon SS, Jolley CJ, Shrikrishna D. ACE and response to pulmonary rehabilitation in COPD: Two observational studies. BMJ Open Respiratory Research. 2017;4: 000165.
- Pabst S, Theis B, Gillissen A. Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease. European Journal of Medical Research. 2009;14(4): 177–181.
- Xu G, Fan G, Sun Y, Yu L, Wu S, Niu W. Association of angiotensin-converting enzyme gene I/D polymorphism with chronic obstructive pulmonary disease: A meta-analysis. Journal of the Renin-Angiotensin-Aldosterone System 2018;13: 2435–2446.
- Kanazawa H, Otsuka T, Hirata K, Yoshikawa J. Association between the angiotensin converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest. 2002;121: 697–701.
- Cox R, Bouzekri N, Martin S. Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Human Molecular Genetics. 2002;11: 2969–2977.
- Ahsan A, Ram R, Baig MA. ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clinical Biochemistry. 2004;37: 1037–1040.
- Kuzubova NA, Chukhlovin AB, Morozova EB, Totolian AA, Titova ON. Common intronic D variant of ACE gene is associated with endothelial dysfunction in COPD. Respiratory Medicine. 2013;107: 1217–1221.